BIO Letter To Vice President Gore

August 29, 2000

The Honorable Albert Gore, Jr.The Vice President of the United StatesWashington, D.C. 20500

Dear Mr. Vice President:

As the presidential campaigns begin to focus...

BIO Letter To Governor Bush

August 29, 2000

The Honorable George W. BushGovernor of TexasP.O. Box 12428Austin, Texas 78711

Dear Governor Bush:

As the presidential campaigns begin to focus intently on seniors...

BIO Asks Presidential Candidates To Address Biotech Contributions To Seniors' Health In Drug Plans

WASHINGTON, D.C., August 29, 2000 - Carl B. Feldbaum, president of the Biotechnology Industry Organization, issued the following statement on the national debate over seniors' access to...

BIO Statement Regarding Purported New Findings on BT Corn and Monarch Butterflies

(Dr. Val Giddings, vice president for food and agriculture of the Biotechnology Industry Organization [BIO] issued the following statement in response to a paper by Dr. John Obrycki published...

Stephan Lawton Joins BIO As Vice President For Regulatory Affairs, General Counsel

WASHINGTON, D.C. (July 27, 2000) Biotechnology Industry Organization (BIO) President Carl B. Feldbaum today announced that Stephan Lawton, a senior partner in the Washington law firm of Hogan and...

BIO Applauds Dismissal of Greenpeace Lawsuit Against Bt Crops

WASHINGTON, D.C. (July 25, 2000) The Biotechnology Industry Organization (BIO) today applauded dismissal in federal court of a Greenpeace lawsuit against Bacillus thuringiensis (Bt) crops.

More Than One-Quarter Billion People Benefit From Medical Biotechnology

WASHINGTON, D.C. (July 21, 2000) A Biotechnology Industry Organization (BIO) survey found that more than one-quarter billion people worldwide have benefited from biotech drugs and vaccines.


BIO Statement Regarding Formation of Congressional Biotechnology Caucus

(Carl B. Feldbaum, president of the Biotechnology Industry Organization [BIO] issued the following statement today regarding the formation of the Congressional Biotechnology Caucus.)


BIO: Reimportation Of Prescription Drugs Puts Patients At Risk

WASHINGTON, D.C. (July 18, 2000)- Biotechnology IndustryOrganization (BIO) President Carl B. Feldbaum said BIO supports the FDA’s powers regarding reimportation of drugs from Mexico and Canada and...

BIO Members Testify before House Judiciary Subcommittee

Executives from two Biotechnology Industry Organization (BIO) member companies testified today at a U.S. House Judiciary subcommittee oversight hearing on gene patents and other genomic inventions.